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SCHEDULED AUTOLOGOUS BLOOD DONATION AT THE TIME OF CARDIAC CATHETERIZATION 
IN INFANTS AND CHILDREN 
Kazuaki Fukahara, MD, a Arata Murakami, MD, a Tetsuyuki Ueda, MD, a Yoshinori Doki, MD, a 
Shinichi Tsubata, MD, b Fukiko Ichida, MD, b and Takuro Misaki, MD, a Toyarna, Japan 
Preoperative autologous blood donation is commonly 
performed to avoid homologous blood transfusion during 
cardiac operations in adult patients. 1 However, autolo- 
gous blood donation for children is hampered by technical 
problems including lack of an adequate blood collection 
system and acute anemia fter blood collection. Given the 
life span of children, it is most important o avoid the 
complications of homologous transfusion. 2 We describe a
technique of scheduled autologous blood donation during 
preoperative cardiac catheterization and examine the 
efficacy and safety of this method for use in infants and 
children. 
Technique. Cardiac catheterization was performed 
about 2 weeks before elective operations in infants and 
children weighing at least 5 kg. Autologous blood dona- 
tion was performed in patients with a hematocrit value of 
33% or more and a hemoglobin value of 11 gm/dl or more. 
Sedation was achieved with thiopental sodium and local 
anesthesia was achieved with lidocaine hydrochloride. 
Sheaths were inserted into the femoral artery and vein. 
After hemodynamic measurements, but before contrast 
angiography, 10 ml/kg of blood was collected via the 
arterial sheath. The same volume of lactated Ringer's 
solution was infused at the same rate through the venous 
sheath. 
Collected blood was stored as packed red cells and 
plasma or as whole blood. Blood erythropoietin concen- 
trations were measured before and after blood collection, 
and recombinant human erythropoietin (100 U/kg) was 
administered intravenously to acyanotic patients on the 
first and seventh days after blood collection. Cyanotic 
patients were not treated with recombinant human eryth- 
ropoietin. Each patient was given ferrous sulfate (2 mg/ 
kg) orally every day. 
Results. From October 1995 through September 1997, 
preoperative autologous blood donation was performed in 
27 children, including 13 infants (16 boys and 11 girls). 
Their ages ranged from 6 months to 6 years, 8 months 
(average 1.9 -+ 2.1 years). Their body weights ranged from 
5.8 kg to 20.2 kg (average 9.7 -+ 5.5 kg). The patients 
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included 21 acyanotic patients (10 with ventricular septal 
defect, eight with atrial septal defect, two with congenital 
coronary artery fistula, and one with ventricular septal 
defect plus pulmonic stenosis) and six cyanotic patients 
(three with tetralogy of Fallot and one patient each with 
pulmonary atresia plus ventricular septal defect, pulmo- 
nary atresia with intact ventricular septum, and single 
ventricle with pulmonic stenosis). All cyanotic patients 
received Blalock-Taussig shunts. Surgery was postponed 
beyond the expiration date of the autologous blood pres- 
ervation in two patients who had upper respiratory tract 
infections. The preserved blood was infused into the one 
patient who was not cyanotic. Of the 27 patients who 
underwent preoperative autologous blood donation, 25 
underwent cardiac operations. The surgical method was 
anatomic radical operation for all of the patients except 
one with single ventricle and pulmonic stenosis, who 
underwent a bidirectional Glenn shunt with the use of 
cardiopulmonary b pass (CPB). 
The period between donation and surgery was 5 to 21 
days (average 15.4 -+ 5.6 days). Autologous blood was 
used as priming volume for CPB in six patients, to support 
CPB in seven patients, and for infusion after discontinu- 
ation of CPB in 12 patients. No complications related to 
autologous blood donation, autologous transfusion, or 
recombinant human erythropoietin administration were 
observed. 
Nineteen patients (76%) underwent surgery without 
homologous blood transfusion. Of the 20 acyanotic pa- 
tients, 17 (85%) underwent surgery without homologous 
blood transfusion. However, three of the five cyanotic 
patients required homologous blood transfusion. 
The blood erythropoietin concentration before autolo- 
gous blood donation was 14.2 + 4.6 mU/ml in the 
acyanotic patients and 19.8 -+ 7.2 mU/ml in the cyanotic 
patients (p < 0.05). The rate of improvement in anemia 
from autologous blood collection until surgery was signif- 
icantly higher in cyanotic patients than that in acyanotic 
patients (0.19 _+ 0.08 gm/dl per day in the acyanotic 
patients and 0.25 + 0.13 gm/dl per day in the cyanotic 
patients, p -< 0.05). 
Comment. In our institution, four procedures are used 
to allow transfusion-free cardiac operations in infants and 
children: (1) preoperative autologous blood donation, (2) 
administration ofrecombinant human erythropoietin, 3 (3) 
decreasing the priming volume for CPB, and (4) use of 
blood cell scavenger techniques in CPB. 4 We have devel- 
oped a method of preoperative autologous blood dona- 
tion at the time of cardiac catheterization i  infants and 
children. The benefits of this technique include the fact 
that blood can be collected uring complete sedation with 
minimal patient discomfort and that blood collection in 
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the cardiac catheterization laboratory allows monitoring 
of hemodynamics. 
In the present study, the combined use of autologous 
blood donation at cardiac catheterization a d treatment 
with recombinant human erythropoietin acyanotic pa- 
tients resulted in a high percentage of transfusion-free 
operations. Therefore this method may be useful in 
preventing transfusion-transmitted diseases. In contrast, 
in cyanotic patients, the transfusion-free surgery rate was 
low despite high blood erythropoietin concentrations and 
high recovery rate from anemia after autologous blood- 
collection until the operation. On the basis of our findings, 
the strategy for transfusion-free cardiac operations for 
cyanotic patients hould be examined further. 
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SUCCESSFUL BRIDGING TO CARDIAC TRANSPLANTATION IN A DYSTROPHIC INFANT WITH 
THE USE OF A NEW PARACORPOREAL PNEUMATIC PUMP 
Michael Weyand, MD, a Deniz Kececioglu, MD, b Christof Schmid, MD, a Hans G. Kehl, MD, b Rene Tandler, MD, a 
Heinz Michael Loick, MD, c and Hans H. Scheld, MD, a Meunster, Germany 
During the past decade, treatment of end-stage cardiac 
failure in adult patients with different forms of paracor- 
poreal or implantable mechanical assist devices used as 
bridges to transplantation has become routine in many 
centers throughout the world. Survival after bridging and 
consecutive heart transplantation is comparable with that 
of nonbridged recipients if mechanical assistance lasts 
long enough to allow complete recovery of secondary 
organ dysfunction. However, no such mechanical assist 
device was available for neonates and smaller infants 
because of size incompatibility until recently. 1-3 We report 
on our first experience with the MEDOS HIA system 
(MEDOS GmbH, Steinfurth, Germany) as a bridge to 
cardiac transplantation in a dystrophic infant, followed by 
successful cardiac transplantation. 
A female child weighing 3490 gm was born on June 6, 
1996. Delivery (Apgar scores at 1, 5, and 10 minutes were 
10) and the early postpartum period was uneventful. At 
the age of 9 weeks, however, the child began having fever, 
shortness of breath, and sinus tachycardia. A chest x-ray 
film demonstrated right lower lobe infiltration suggestive 
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of pneumonia but, more important, a silhouette of a huge 
heart. After referral to our institution, echocardiography 
confirmed massive enlargement of both ventricles. Left 
ventricular fractional shortening was calculated as 8%. 
Because she was in New York Heart Association class 
III-IV, the child was treated with digitalis, diuretics, and 
supportive oxygen at first. However, as the child's condi- 
tion deteriorated further, with weight loss despite hyper- 
caloric feeding and requirement of intravenous dopamine 
and dopexamine, she was listed for cardiac transplanta- 
tion. The diagnosis was dilative cardiomyopathy, because 
no evidence of viral myocarditis was obtained. After 5 
months on the waiting list, the child (3400 gm) had two 
episodes of cardiovascular collapse necessitating external 
heart massage and high-dose catecholamine support, as 
well as intubation and mechanical ventilation. Because no 
donor heart was available, the decision was made to use 
the paracorporeal MEDOS HIA system. Normothermic 
extracorporeal circulation was established with the use of 
a single atrial cannula. The arterial cannula was inserted 
into the proximal part of the aortic arch, leaving the 
ascending aorta untouched for the assist device. With the 
heart beating, a right-angled 18F venous cannula was 
placed into the left atrium via the intraatrial groove, 
secured by two purse-string sutures of 5-0 monofilament 
polypropylene.4.5 The cannula was tunneled below the 
right costal margin to exit the skin in the right epigastrium. 
The arterial 18F cannula was connected to the ascending 
aorta via a 4 mm polytetrafluorethylene graft, which 
exited the skin in the left epigastrium. After meticulous 
deairing, both tubes were connected to the 10 ml paracor- 
poreal ventricle placed onto the abdominal wall. The air 
driveline was connected to the console, left ventricular assist 
